← brief for 2026-09-26 · Slowing decline

Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin.

Key takeaways

A diabetes drug called empagliflozin changed blood markers in 42 people over 1 to 3 months. It raised magnesium and hemoglobin levels. This study shows a link, not proof of cause.

Who did this work

Habeos EE · Markantes GK · Parthymou A · Dimitropoulos K · Habeos GI · Papasotiriou M · Marangos M · Chartoumpekis DV

Source

Article · PubMed, the drug frontier · 2026 Sep 8
https://pubmed.ncbi.nlm.nih.gov/42792758/